• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL2000339 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2020-12-19 view
JXHL2000335 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2020-12-19 view
JXHL2000358 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2021-01-04 view
JXHL2000357 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2021-01-04 view
JXHL2000338 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2020-12-19 view
JXHL2000356 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2021-01-04 view
JXHL2000337 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2020-12-19 view
JXHL2000360 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2021-01-04 view
JXHL2000336 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2020-12-21 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2020-12-19 view
JXHL2000359 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-01-05 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH In Review 2021-01-04 view
JXHL2300214 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400196 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-08-07 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400016 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-01-19 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300221 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2101062 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2021-05-27 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHB2400164 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2024-09-30 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHB2400108 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Supplementary Application 2024-06-14 Boehringer Ingelheim International GmbH;Vetter Development Services USA Inc view
JXHL2300233 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-19 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2300222 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2023-09-12 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view
JXHL2400197 BI 456906 注射液 survodutide Injection Chemical Drugs(1) Import Drug Application 2024-08-07 Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH view